• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Renal stones in women linked with increased risk of coronary heart disease

bys25qthea
July 24, 2013
in Cardiology, Chronic Disease, Nephrology
Reading Time: 3 mins read
Renal stones in women linked with increased risk of coronary heart disease
Share on FacebookShare on TwitterShare on LinkedIn

 Image: PD

1. An increased risk of coronary heart disease was found women with a history of renal stones.

2. The same association was not demonstrated in men with similarly adjusted variables.

Evidence Rating Level:  2 (Good)

Study Rundown: Nephrolithiasis is a common disease with increasing prevalence. Its relation to other systemic diseases, especially those of cardiac etiology, has previously been implicated in clinical studies. This study sought to better analyze the relation between the presence of kidney stone disease and risk of future coronary heart disease. After an analysis that adjusted for numerous variables, there was a moderate, though statistically significant, increase in risk of coronary heart disease in women with a history of renal stones. The same association, however, was not demonstrated in men with similarly adjusted variables. Though this study included over 200,000 participants and accounted for a host of variables, there were still some limitations in the study. The study did not have renal function data of participants but used a separate study’s data to postulate a conclusion for this study. Considering the close relationship between renal and cardiovascular functioning, and the potential effects of stones on renal function, such data would be an important piece to this puzzle. Furthermore, both disease states have numerous lifestyle and medical risk factors, making it extremely difficult to include and account for all in one study, thus a common risk factor to both diseases can easily be missed. Nonetheless, this study provides insight into a potential association between two very common disease states.

Click to read the study, published today in JAMA

RELATED REPORTS

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

Dietary changes and pharmacologic interventions may prevent recurrent nephrolithiasis

Relevant Reading: Kidney stones associate with increased risk of myocardial infarction

In-Depth [prospective cohort study]: This study included 45,748 men and 196,357 women. The main study outcomes were defined as fatal or nonfatal myocardial infarction, or coronary revascularization. Follow up included biennial questionnaires regarding occurrence of stones or study outcomes with confirmation via medical records. Separate age-adjusted Hazard Ratios (HR) demonstrated an increased risk of cardiac outcomes with a history of renal stones. However, when 2 different multivariable-adjusted HR’s were calculated only the female cohorts showed any significant difference in outcome rates. After combining both female cohorts, multivariable-adjusted analysis demonstrated HR’s of 1.30 (95%CI, 1.04-1.62) for total coronary heart disease, 1.26 (95%CI, 1.11-1.43) for any myocardial infarction, and 1.29 (95%CI, 1.07-1.55) for revascularization in women with history of stones. There were no significant differences found in men.

By Sam Moradian and Brittany Hasty 

More from this author: Rates of major CV procedures differ between Medicare Advantage and fee-for-service beneficiaries, Increase in white matter hyperintensities seen in migraine patients,  Zoledronic acid therapy reduces risk of fracture in men with osteoporosis

© 2013 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: coronary heart diseaseheart diseasekidneyrenal stones
Previous Post

Increased risk of hospitalization following the release of inmates

Next Post

Echocardiographic screening does not improve all-cause mortality

RelatedReports

An illustration featuring a heart within a house, with a stethoscope, a scale, and medication, symbolizing heart failure home hospital care.
Artificial Intelligence

An artificial intelligence model demonstrates the potential for improving the efficiency of structural heart disease screening using electrocardiograms

October 21, 2026
Being overweight and obese associated with increased incidence of chronic kidney disease
Nephrology

Dietary changes and pharmacologic interventions may prevent recurrent nephrolithiasis

March 23, 2026
Solitary kidney not associated with contrast-induced nephropathy
Chronic Disease

Albuminuria shows a stronger association with kidney failure than proteinuria

November 20, 2025
Neurocognitive deficits in congenital heart disease may not worsen with age
AI Roundup

Artificial intelligence stethoscope detects heart disease in seconds

September 16, 2025
Next Post
Echocardiographic screening does not improve all-cause mortality

Echocardiographic screening does not improve all-cause mortality

Pre-operative transcranial magnetic stimulation useful for language mapping

Phase 3 trial fails to demonstrate benefit of semagacestat in Alzheimer’s disease

High rate of hernia recurrence with biologic mesh repair

Transfusion worsens outcomes for HCV+ liver transplant recipients

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
  • Elevated low-density lipoprotein cholesterol is a risk factor for atherosclerotic disease irrespective of familial hypercholesterolemia status
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.